FAS and metabolic dysfunction-associated steatotic liver disease: The present study demonstrated that TFCP regulated hepatic fatty acid synthesis through the reduced expression of fatty acid synthesis regulators, including SREBP, FAS, and ACC, and also suppressed NAFLD.